Entries of Luger, T. on the publication server

Schlinqensiepen, K., Oettle, H., Seufferlein, T., Luger, T., Schmid, R.M., von Wiehert, G., Endlicher, E., Garbe, C., Kaehler, K.C. and Enk, A. (2011) 1233 POSTER Phase l/lI Study With Trabedersen (AP 12009) Monotherapy for the Treatment of Patients With Advanced Pancreatic Cancer, Malignant Melanoma or Colorectal Carcinoma. European Journal of Cancer 47, S154. Fulltext not available.

Oettle, H., Hilbig, A., Seufferlein, T., Tsianakas, A., Luger, T., Schmid, R. M., von Wichert, G., Endlicher, E., Garbe, C., Kaehler, K. K., Hauschild, A., Enk, A., Kiessling, P., Schmaus, S., Heinrichs, H. and Schlingensiepen, K. (2011) Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma. Journal of Clinical Oncology 29 (15_sup), p. 2513. Fulltext not available.

Goerdt, S., Kolde, G., Bonsmann, G., Hamann, K., Czarnetzki, B., Andreesen, Reinhard, Luger, T. and Sorg, C. (1993) Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. The Journal of pathology 170 (4), pp. 421-7. Fulltext not available.